Elsevier

Progress in Cardiovascular Diseases

Volume 18, Issue 3, November–December 1975, Pages 181-199
Progress in Cardiovascular Diseases

Abnormalities in the regional circulations accompanying congestive heart failure

https://doi.org/10.1016/0033-0620(75)90010-9Get rights and content

Abstract

In congestive heart failure, patients appear to have a limited ability to dilate their resistance vessels in skeletal muscle in response to a metabolic stimulus. This is true whether the metabolic stimulus is ischemia, dynamic, or static exercise. The mechanism for this limited arteriolar capacity is at least twofold; an increased sodium content of the vessels as well as an increased tissue pressure which is seen in edematous states. This can be considered a positive compensatory mechanism in that it helps to maintain systemic arterial pressure during exercise when the cardiac output fails to increase normally. If the resistance vessels were to dilate normally, then in the face of a limited cardiac output, exercise syncope would be expected to occur. Such a situation does, in fact, occur when patients with congestive heart failure are subjected to intense diuresis. The price paid by heart failure patients for the maintenance of arterial pressure during exercise is an earlier shift to anaerobic metabolism. Because of the limited blood flow to exercising muscle, there is an increased oxygen extraction as the blood traverses the metabolically active muscular beds. This increased oxygen extraction, however, is not sufficient to allow aerobic metabolism to proceed normally. Hence, patients with heart failure are more subject to developing metabolic acidosis during exercise and at lesser levels of exertion than their normal counterparts. This may partly explain the greater oxygen debt seen in patients with congestive heart failure following exercise.

A second abnormality present in the peripheral circulations of patients with congestive heart failure is an increased sympathetic alpha adrenergic tone as well as an increased level of circulating catecholamines. This is most true in symptomatic patients at rest and during exertion in most patients with heart failure who are limited in their exercise capacity. This increased sympathetic tone helps to explain the seemingly paradoxical cardiovascular response to certain maneuvers such as head up-tilting and to certain drugs such as digitalis. During exercise, the sympathetic nervous system appears to be activated to a greater extent in patients with congestive heart failure and, as expected, the circulations with the greatest population of alpha receptors, the cutaneous, renal, and splanchnic circulations, appear to suffer the most from an inadequate blood flow. The failure to dilate the cutaneous circulation in response to a thermal stress makes these patients particularly susceptible to cardiac failure in a hot and humid environment. The failure to handle even the normal thermogenesis of mild exertion helps to explain the slight temperature elevations so commonly seen when patients are hospitalized with acute cardiac failure. The failure to cool muscles appropriately during exercise might even contribute to a greater alactic portion of the oxygen debt, as well.69

In the capacitance vessels of the limbs of heart failure patients, there is an increased venous tone, as well. This is minimally related to increased sympathetic efferent impulses to the cutaneous veins and increased circulating catecholamines but is majorly explained on the basis of local factors that go into determining venous tone. The most important local factor that can reduce the venous volume is edema. Since the venous volume of the limbs if reduced only slightly by the increased sympathetic tone in congestive heart failure, it might be expected that drugs such as morphine which seem to work by producing a central nervous system “sympatholysis” would be expected to increase the venous volume of the limbs only minimally. Thus, in acute pulmonary edema, if morphine induces a peripheral pooling of blood, it is likely that it is through its arteriolar dilator mechanism and the perfusion of previously unperfused vascular beds, leading to a passive filling of the venous system.

References (71)

  • GC Patterson et al.

    Reactive hyperemia in the human forearm

    Clin Sci

    (1955)
  • JE Wood et al.

    The mechanism of limb segment reactive hyperemia in man

    Circ Res

    (1955)
  • R Zelis et al.

    A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

    J Clin Invest

    (1968)
  • R Zelis et al.

    Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

    J Clin Invest

    (1970)
  • JP Remensnyder et al.

    Functional sympathtolysis during muscular activity

    Circ Res

    (1962)
  • T Strandell et al.

    The effect in humans of increased sympathetic activity on the blood flow to active muscle

    Acta Med Scand

    (1967)
  • J Conway

    A vascular abnormality in hypertension: A study of blood flow in the forearm

    Circulation

    (1963)
  • L Tobain et al.

    Sodium and potassium in the walls of arterioles in experimental renal hypertension

    J Clin Invest

    (1961)
  • R Zelis et al.

    Arterial sodium content in experimental congestive heart failure

    Circulation

    (1970)
  • R Zelis et al.

    Diminished forearm arteriolar dilator capacity produced by mineralocorticoid-induced salt retention in man. Implications concerning congestive heart failure and vascular stiffness

    Circulation

    (1970)
  • S Rodbard et al.

    Post-occlusion hyperemia: Study on a model

    Q J Exp Physiol

    (1969)
  • R Zelis et al.

    Influence of experimental edema of metabolically determined blood flow

    Circ Res

    (1974)
  • CB Higgins et al.

    Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs

    Circ Res

    (1972)
  • R Zelis et al.

    Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg exercise in normal subjects and in patients with heart failure

    Circ Res

    (1969)
  • RS Kramer et al.

    Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion

    Circulation

    (1968)
  • AL Mark et al.

    Adrenergic control of the peripheral circulation in cardiomyopathic hamsters with heart failure

    Circ Res

    (1973)
  • PG Schmid et al.

    Neurogenic control of vascular tone in heart failure

    Clin Res

    (1972)
  • PG Schmid et al.

    Differences in neural control of vascular resistance in right to left heart failure

    Circulation

    (1974)
  • KB Hayduk et al.

    Renin activity and norepinephrine, cation and water contents of cardiovascular tissue of dogs with congestive heart failure and ascites

    Can J Physiol Pharmacol

    (1970)
  • W Brigden et al.

    Postural changes in peripheral blood flow in cases with left heart failure

    Clin Sci

    (1950)
  • DA Blair et al.

    Vasomotor responses in the human arm during leg exercise

    Circ Res

    (1961)
  • BS Bevegard et al.

    Reaction in man of resistance and capacity vessels in forearm and hand to leg exercise

    J Appl Physiol

    (1966)
  • HAV Muth et al.

    Further studies of blood flow in the resting arm during supine leg exercise

    Clin Sci

    (1958)
  • GE Burch et al.

    The burden of a hot and humid environment on the heart

    Mod Concepts Cardiovasc Dis

    (1970)
  • CL Morgan et al.

    Sweating and congestive heart failure

    N Engl J Med

    (1963)
  • Cited by (97)

    • Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities

      2022, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      Moreover, the increased ergoreflex sensitivity in HF patients induces autonomic imbalance and exercise pressor reflex, as well as an abnormal ventricular-arterial coupling in certain heart failure with preserved ejection fraction (HFpEF), further contributing to the cardiac workload and exercise intolerance (EI) [7–9]. These cardiac and peripheral hemodynamic disorders and consequent local circulatory disturbances in skeletal muscle were initially thought to be the primary cause of muscle dysfunction in HF patients [10–12]. Notably, in addition to the decreased capillary density and microcirculatory disorders, myofibers themselves can undergo structural and functional abnormalities in response to multiple neural stimulation patterns, loading conditions, substrate availability, hormonal signaling, and metabolic status in the context of HF, which received increasing attention as an even more promising therapeutic target since the 1970 s [13,14].

    • Cardiovascular Biomarkers in Exhaled Breath

      2012, Progress in Cardiovascular Diseases
      Citation Excerpt :

      Increased NO in heart failure is presumably to counter vasoconstrictive forces and is correlated with severity of heart failure. Plasma nitrate, an index of whole-body endogenous NO production, is significantly increased in patients with heart failure.36-38 Significant dysregulation of endogenous NO production has been shown in patients with advanced ischemic or nonischemic cardiomyopathy when compared with control subjects.39

    • Alterations in Diaphragmatic and Skeletal Muscle in Heart Failure

      2010, Heart Failure: A Companion to Braunwald's Heart Disease Expert Consult
    • Why does chronic heart failure cause breathlessness and fatigue?

      2007, Progress in Cardiovascular Diseases
      Citation Excerpt :

      There is arterial smooth muscle hypertrophy and activation of fibroblasts with hyalinosis of the vascular wall.114 These changes lead to reduced arterial compliance115 and hence to poor vasodilation in skeletal muscle arterioles during exercise.116 In addition, in CHF, there is a reduced response to endogenous vasodilatory stimuli,117,118 to infused hyperosmolar solutions,119 and to pharmacologic agents.120

    View all citing articles on Scopus

    Supported in part by grant 71-888 from the American Heart Association and grants HL 14780, HL 17853, and HL 17954 of the National Institutes of Health. Also supported in part by grants from the American Heart Association, South Central Pennsylvania Affiliate, and the Sam Ostrow Cardiology Research Fund.

    View full text